113
Views
0
CrossRef citations to date
0
Altmetric
Article Commentaries

Anticipation in hematopoietic malignancies: biology, bias, or both?

Pages 3070-3072 | Received 25 Jul 2021, Accepted 05 Aug 2021, Published online: 18 Aug 2021

References

  • Jones S, Brooks-Wilson A. Anticipation in multiple-case lymphoid cancer families after controlling for ascertainment biases. Leuk Lymphoma. 2021;.
  • Paulson H. Repeat expansion diseases. Handb Clin Neurol. 2018;147:105–123.
  • Murmann AE, Yu J, Opal P, et al. Trinucleotide repeat expansion diseases, RNAi, and cancer. Trends Cancer. 2018;4(10):684–700.
  • Ishiura H, Tsuji S. Advances in repeat expansion diseases and a new concept of repeat motif-phenotype correlation. Curr Opin Genet Dev. 2020;65:176–185.
  • Horwitz M, Goode EL, Jarvik GP. Anticipation in familial leukemia. Am J Hum Genet. 1996;59:990–998.
  • Horwitz M. The genetics of familial leukemia. Leukemia. 1997;11(8):1347–1359.
  • Goldin LR, Sgambati M, Marti GE, et al. Anticipation in familial chronic lymphocytic leukemia. Am J Hum Genet. 1999;65(1):265–269.
  • Yuille MR, Houlston RS, Catovsky D. Anticipation in familial chronic lymphocytic leukaemia. Leukemia. 1998;12(11):1696–1698.
  • Wiernik PH, Ashwin M, Hu XP, et al. Anticipation in familial chronic lymphocytic leukaemia. Br J Haematol. 2001;113(2):407–414.
  • Shugart YY, Hemminki K, Vaittinen P, et al. Apparent anticipation and heterogeneous transmission patterns in familial hodgkin's and non-Hodgkin's lymphoma: report from a study based on Swedish cancer database. Leuk Lymphoma. 2001;42(3):407–415.
  • Alexandrescu DT, Wiernik PH. The influence of parental age and gender on anticipation in familial B-cell malignancies. Med Oncol. 2007;24(1):55–62.
  • Awan H, Jønsson V, Johannesen TB, et al. Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders. Transl Oncogenomics. 2010;4:1–9.
  • Tegg EM, Thomson RJ, Stankovich JM, et al. Anticipation in familial hematologic malignancies. Blood. 2011;117(4):1308–1310.
  • Lowenthal RM, Tegg EM, Dickinson JL. The familial tasmanian haematological malignancies study (FaTHMS): its origins, its history and the phenomenon of anticipation. Transfus Apher Sci. 2013;49(2):113–115.
  • Wiernik PH, Wickramasinghe D, Dutcher JP. Families with both hodgkin lymphoma and multiple myeloma in their pedigrees. Clin Adv Hematol Oncol. 2015;13(4):257–260.
  • Landgren O, Goldin LR, Kristinsson SY, et al. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden. Blood. 2008;112(6):2199–2204.
  • Benzow KA, Koob MD, Condie A, et al. Instability of CAG-trinucleotide repeats in chronic lymphocytic leukemia. Leuk Lymphoma. 2002;43(10):1987–1990.
  • Auer RL, Dighiero G, Goldin LR, et al. Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia. Br J Haematol. 2007;136(1):73–79.
  • Vulliamy T, Marrone A, Szydlo R, et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36(5):447–449.
  • Marrone A, Walne A, Dokal I. Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr Opin Genet Dev. 2005;15(3):249–257.
  • Armanios M, Chen JL, Chang YP, et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci USA. 2005;102(44):15960–15964.
  • Tabori U, Nanda S, Druker H, et al. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res. 2007;67(4):1415–1418.
  • Trkova M, Prochazkova K, Krutilkova V, et al. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age. Cancer. 2007;110(3):694–702.
  • Martinez-Delgado B, Yanowsky K, Inglada-Perez L, et al. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLOS Genet. 2011;7(7):e1002182.
  • Peker Eyüboğlu İ, Yenmiş G, Bingöl EN, et al. Next-Generation sequencing identifies BRCA1 and/or BRCA2 mutations in women at high hereditary risk for breast cancer with shorter telomere length. OMICS. 2020;24(1):5–15.
  • Pavanello S, Varesco L, Gismondi V, et al. Leucocytes telomere length and breast cancer risk/ susceptibility: a case-control study. PLOS One. 2018;13(5):e0197522.
  • Seguí N, Pineda M, Guinó E, et al. Telomere length and genetic anticipation in lynch syndrome. PLOS One. 2013;8(4):e61286.
  • Dor Y, Cedar H. Principles of DNA methylation and their implications for biology and medicine. Lancet. 2018;392(10149):777–786.
  • Horvath S, Raj K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018;19(6):371–384.
  • Bell CG, Lowe R, Adams PD, et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 2019;20(1):249.
  • Salameh Y, Bejaoui Y, El Hajj N. DNA methylation biomarkers in aging and age-related diseases. Front Genet. 2020;11:171.
  • Sun F, Higashimoto K, Awaji A, et al. The extent of DNA methylation anticipation due to a genetic defect in ICR1 in Beckwith-Wiedemann syndrome. J Hum Genet. 2019;64(9):937–943.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.